Of importance is to consider evaluating the effects of tacrolimus on local ovarian and systemic levels and signaling pathways of TGFβ and its effects on the functional proliferation and differentiation of the CD4+CD25+ CD127low T cells in PCOS. This evidence concerns the gene TGFB1 and polycystic ovary syndrome.